High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae

Journal of Biotechnology

Volumn 111, Issue 3, 2004, Pages 319-333

  Razanskiene, Aušra ^a   Schmidt, Jonas ^b   Geldmacher, Astrid ^b,f   Ritzi, Andreas ^b   Niedrig, Matthias ^c   Lundkvist, Åke ^d,e   Krüger, Detlev H ^b   Meisel, Helga ^b   Sasnauskas, Kestutis ^a   Ulrich, Rainer ^b,g  

^a VILNIUS UNIVERSITY   (Lithuania)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f CRUCELL HOLLAND BV   (Netherlands)

^g FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Antigenicity; Hantavirus; Immunogenicity; Recombinant nucleocapsid protein; Yeast

Indexed keywords

CELLS; DEGRADATION; NUCLEIC ACIDS; PROTEINS; YEAST;

NUCLEOCAPSID PROTEINS; PROTEIN DERIVATIVES;

BIOTECHNOLOGY;

NICKEL COMPLEX; NUCLEIC ACID; NUCLEOCAPSID PROTEIN;

ARTICLE; CHROMATOGRAPHY; FREEZE DRYING; HANTAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PUUMALA VIRUS; SACCHAROMYCES CEREVISIAE; SEROLOGY; VIRUS STRAIN; YEAST; YEAST CELL;

ANIMALS; CLONING, MOLECULAR; HANTAVIRUS; NUCLEOCAPSID PROTEINS; PROTEIN ENGINEERING; RABBITS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

DOBRAVA VIRUS; HANTAVIRUS; PUUMALA VIRUS; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 3042749236     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2004.04.010     Document Type: Article

References (76)

1. Adams S.E., Dawson K.M., Gull K., Kingsman S.M., Kingsman A.J. The expression of hybrid HIV:Ty virus-like particles in yeast. Nature. 329:1987;68-70
2. Alfadhli A., Love Z., Arvidson B., Seeds J., Willey J., Barklis E. Hantavirus nucleocapsid protein oligomerization. J. Virol. 75:2001;2019-2023
3. Alfadhli A., Steel E., Finlay L., Bachinger H.P., Barklis E. Hantavirus nucleocapsid protein coiled-coil domains. J. Biol. Chem. 277:2002;27103-27108
4. Avsic-Zupanc T., Toney A., Anderson K., Chu Y.K., Schmaljohn C. Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae. J. Gen. Virol. 76:1995;2801-2808
5. Barr P.J., Steimer K.S., Sabin E.A., Parkes D., George-Nascimento C., Stephans J.C., Powers M.A., Gyenes A., Van Nest G.A., Miller E.T., et al. Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. Vaccine. 5:1987;90-101
6. Beesley K.M., Francis M.J., Clarke B.E., Beesley J.E., Dopping-Hepenstal P.J., Clare J.J., Brown F., Romanos M.A. Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties. Biotechnology (NY). 8:1990;644-649
7. Brummer-Korvenkontio M., Henttonen H., Vaheri A. Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica. Scand. J. Infect. Dis. Suppl. 36:1982;88-91
8. Center for Biologics Evaluation and Research, United States Food and Drug Administration (1993). CBER guidelines: points to consider in the characterization of cell lines used to produce biologicals.
9. Cifire, F., 1997. Expression und immunologische Charakterisierung des Nukleokapsidproteins vom Hantavirusisolat Vranica. PhD Thesis, Free University, Berlin, Germany.
10. Dargeviciute A., Brus S.K., Sasnauskas K., Krüger D.H., Meisel H., Ulrich R., Lundkvist Å. Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine. 20:2002;3523-3531
11. de Carvalho Nicacio C., Sällberg M., Hultgren C., Lundkvist Å. T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model. J. Gen. Virol. 82:2001;129-138
12. de Carvalho Nicacio C., Gonzalez Della Valle M., Padula P., Bjorling E., Plyusnin A., Lundkvist Å. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. J. Virol. 76:2002;6669-6677
13. Dzagurova T., Tkachenko E., Slonova R., Ivanov L., Ivanidze E., Markeshin S., Dekonenko A., Niklasson B., Lundkvist Å. Antigenic relationships of hantavirus strains analysed by monoclonal antibodies. Arch. Virol. 140:1995;1763-1773
14. Feldmann H., Sanchez A., Morzunov S., Spiropoulou C.F., Rollin P.E., Ksiazek T.G., Peters C.J., Nichol S.T. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res. 30:1993;351-367
15. Gedvilaite A., Zvirbliene A., Staniulis J., Sasnauskas K., Krüger D.H., Ulrich R. Segments of Puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice. Viral Immunol. 17:2004;51-68
16. Geldmacher, A., Skrastina, D., Petrovskis, I., Borisova, G., Berriman, J.A., Roseman, A.M., Crowther, R.A., Fischer, J., Shamil Musema, Gelderblom, H.R., Lundkvist, Å., Renhofa, R., Ose, V., Krüger, D.H., Pumpens, P., Ulrich, R., 2004a. An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice. Virology 323, 108-119.
17. Geldmacher A., Schmaler M., Krüger D.H., Ulrich R. Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting and highly cross-reactive immune response in mice. Viral Immunol. 17:2004b;115-122
18. Gött P., Stohwasser R., Schnitzler P., Darai G., Bautz E.K. RNA binding of recombinant nucleocapsid proteins of hantaviruses. Virology. 194:1993;332-337
19. Golovljova I., Sjölander K.B., Lindegren G., Vene S., Vasilenko V., Plyusnin A., Lundkvist Å. Hantaviruses in Estonia. J. Med. Virol. 68:2002;589-598
20. Guthrie Ch., Fink, G.R., 1991. Guide to Yeast Genetics and Molecular Biology. Academic Press Inc., San Diego, USA.
21. Hale A.D., Bartkeviciute D., Dargeviciute A., Jin L., Knowles W., Staniulis J., Brown D.W., Sasnauskas K. Expression and antigenic characterization of the major capsid proteins of human polyomaviruses BK and JC in Saccharomyces cerevisiae. J. Virol. Methods. 104:2002;93-98
22. Hitzeman R.A., Chen C.Y., Hagie F.E., Patzer E.J., Liu C.C., Estell D.A., Miller J.V., Yaffe A., Kleid D.G., Levinson A.D., Oppermann H. Expression of hepatitis B virus surface antigen in yeast. Nucleic Acids Res. 11:1983;2745-2763
23. Hooper J.W., Li D. Vaccines against hantaviruses. Curr. Top. Microbiol. Immunol. 256:2001;171-191
24. Jansen K.U., Rosolowsky M., Schultz L.D., Markus H.Z., Cook J.C., Donnelly J.J., Martinez D., Ellis R.W., Shaw A.R. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine. 13:1995;1509-1514
25. Kaukinen P., Koistinen V., Vapalahti O., Vaheri A., Plyusnin A. Interaction between molecules of hantavirus nucleocapsid protein. J. Gen. Virol. 82:2001;1845-1853
26. Klempa B., Schmidt H.A., Ulrich R., Kaluz S., Labuda M., Meisel H., Hjelle B., Krüger D.H. Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature. J. Virol. 77:2003;804-809
27. Klempa B., Schütt M., Auste B., Ulrich R., Meisel H., Krüger D.H. First molecular identification of human Dobrava virus infection in Central Europe. J. Clin. Microbiol. 42:2004;1322-1325
28. Klepfer S.R., Debouck C., Uffelman J., Jacobs P., Bollen A., Jones E.V. Characterization of rabies glycoprotein expressed in yeast. Arch. Virol. 128:1993;269-286
29. Krüger D.H., Ulrich R., Lundkvist Å. Hantavirus infections and their prevention. Microbes Infect. 3:2001;1129-1144
30. Lee H.W., Lee P.W., Johnson K.M. Isolation of the etiologic agent of Korean hemorrhagic fever. J. Infect. Dis. 137:1978;298-308
31. Lee H.W., Baek L.J., Johnson K.M. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J. Infect. Dis. 146:1982;638-644
32. Lundkvist Å., Fatouros A., Niklasson B. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. J. Gen. Virol. 72:1991;2097-2103
33. Lundkvist Å., Niklasson B. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Arch. Virol. 126:1992;93-105
34. Lundkvist Å., Cheng Y., Sjölander K.B., Niklasson B., Vaheri A., Plyusnin A. Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment. J. Virol. 71:1997;9515-9523
35. Lundkvist Å., Meisel H., Koletzki D., Lankinen H., Cifire F., Geldmacher A., Sibold C., Gött P., Vaheri A., Krüger D.H., Ulrich R. Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Virol. Immunol. 15:2002;177-192
36. Martyn J.C., Gould A.R., Eaton B.T. High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA. Virus Res. 18:1991;165-178
37. McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R. Human hepatitis B vaccine from recombinant yeast. Nature. 307:1984;178-180
38. Meisel H., Lundkvist Å., Gantzer K., Bär W., Sibold C., Krüger D.H. First case of infection with hantavirus Dobrava in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;884-885
39. Musema, S., 1998. Herstellung einer potentiellen HTN-Vakzine und einer bivalenten HTN/PUU-Kombinationsvakzine auf der Basis von chimären Hepatitis B Virus (HBV)-Corepartikeln. Diploma thesis. Humboldt University, Berlin, Germany.
40. Mustonen J., Vapalahti O., Henttonen H., Pasternack A., Vaheri A. Epidemiology of hantavirus infections in Europe. Nephrol. Dial. Transplant. 13:1998;2729-2731
41. Neeper M.P., Hofmann K.J., Jansen K.U. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. Gene. 180:1996;1-6
42. Nemirov K., Vapalahti O., Lundkvist Å., Vasilenko V., Golovljova I., Plyusnina A., Niemimaa J., Laakkonen J., Henttonen H., Vaheri A., Plyusnin A. Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia. J. Gen. Virol. 80:1999;371-379
43. Nozaki C., Makizumi K., Kino Y., Nakatake H., Eto T., Mizuno K., Hamada F., Ohtomo N. Expression of herpes simplex virus glycoprotein B gene in yeast. Virus Res. 4:1985;107-113
44. Palkova Z., Adamec T., Liebl D., Stokrova J., Forstova J. Production of polyomavirus structural protein VP1 in yeast cells and its interaction with cell structures. FEBS Lett. 478:2000;281-289
45. Papa A., Nemirov K., Henttonen H., Niemimaa J., Antoniadis A., Vaheri A., Plyusnin A., Vapalahti O. Isolation of Dobrava virus from Apodemus flavicollis in Greece. J. Clin. Microbiol. 39:2001;2291-2293
46. Pichuantes S., Babe L.M., Barr P.J., Craik C.S. Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein. Proteins. 6:1989;324-337
47. Plyusnin A., Krüger D.H., Lundkvist Å. Hantavirus infections in Europe. Adv. Virus Res. 57:2001;105-136
48. Reip A., Haring B., Sibold C., Stohwasser R., Bautz E.K., Darai G., Meisel H., Krüger D.H. Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch. Virol. 140:1995;2011-2026
49. Reyburn H.T., Roy D.J., Blacklaws B.A., Sargan D.R., McConnell I. Expression of maedi-visna virus major core protein, p25: development of a sensitive p25 antigen detection assay. J. Virol. Methods. 37:1992;305-320
50. Rossi J.L., Gissmann L., Jansen K., Müller M. Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum. Gene Ther. 11:2000;1165-1176
51. Saelens X., Vanlandschoot P., Martinet W., Maras M., Neirynck S., Contreras R., Fiers W., Jou W.M. Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin. Eur. J. Biochem. 260:1999;166-175
52. Sakamoto S., Ide T., Tokiyoshi S., Nakao J., Hamada F., Yamamoto M., Grosby J.A., Ni Y., Kawai A. Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells. Vaccine. 17:1999;205-218
53. Samuel D., Sasnauskas K., Jin L., Beard S., Zvirbliene A., Gedvilaite A., Cohen B. High level expression of recombinant mumps nucleoprotein in Saccharomyces cerevisiae and its evaluation in mumps IgM serology. J. Med. Virol. 66:2002;123-130
54. Samuel, D., Sasnauskas, K., Jin, L., Gedvilaite, A., Slibinskas, R., Beard, S., Zvirbliene, A., Oliveira, S.A., Staniulis, J., Cohen, B., Brown, D., 2003. Development of a measles specific IgM ELISA for use with serum and oral fluid using recombinant measles nucleoprotein produced in Saccharomyces cervisiae. J. Clin. Virol., 121-129.
55. Sasagawa T., Pushko P., Steers G., Gschmeissner S.E., Hajibagheri M.A., Finch J., Crawford L., Tommasino M. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology. 206:1995;126-135
56. Sasnauskas K., Buzaite O., Vogel F., Jandrig B., Razanskas R., Staniulis J., Scherneck S., Krüger D.H., Ulrich R. Yeast cells allow the high-level expression and formation of polyomavirus-like particles. Biol. Chem. 380:1999;381-386
57. Sasnauskas K., Bulavaite A., Hale A., Jin L., Gedvilaite A., Dargeviciute A., Bartkeviciute D., Zvirbliene A., Staniulis J., Brown D.W.G., Ulrich R. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology. 45:2002;308-317
58. Schmaljohn C.S., Jennings G.B., Hay J., Dalrymple J.M. Coding strategy of the S genome segment of Hantaan virus. Virology. 155:1986;633-643
59. Schulz, A., 1994. Charakterisierung eines Hantavirusisolats. Sequenzierung und Expression des Nukleoproteins des Isolats Fojnica. Diploma thesis. Humboldt University, Berlin, Germany.
60. Schütt M., Gerke P., Meisel H., Ulrich R., Krüger D.H. Clinical characterization of Dobrava hantavirus infections in Germany. Clin. Nephrol. 55:2001;371-374
61. Sibold C., Meisel H., Lundkvist Å., Schulz A., Cifire F., Ulrich R., Kozuch O., Labuda M., Krüger D.H. Simultaneous occurrence of Dobrava, Puumala, and Tula hantaviruses in Slovakia. Am. J. Trop. Med. Hyg. 61:1999;409-411
62. Sibold C., Ulrich R., Labuda M., Lundkvist Å., Martens H., Schütt M., Gerke P., Leitmeyer K., Meisel H., Krüger D.H. Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J. Med. Virol. 63:2001;158-167
63. Sjölander K.B., Elgh F., Kallio-Kokko H., Vapalahti O., Hagglund M., Palmcrantz V., Juto P., Vaheri A., Niklasson B., Lundkvist Å. Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica). J. Clin. Microbiol. 35:1997;3264-3268
64. Stolt A., Sasnauskas K., Koskela P., Lehtinen M., Dillner J. Seroepidemiology of the human polyomaviruses. J. Gen. Virol. 84:2003;1499-1504
65. Tavis J.E., Ganem D. Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4107-4111
66. Ulrich R., Hjelle B., Pitra C., Krüger D.H. Emerging viruses: The case "Hantavirus" Intervirology. 45:2002;318-327
67. Valenzuela P., Medina A., Rutter W.J., Ammerer G., Hall B.D. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature. 298:1982;347-350
68. van Regenmortel, M.H.V., Fauquet, C.M., Bishop, D.H.L., Carstens, E.B., Estes, M.K., Lemon, S.M., Maniloff, J., Mayo, M.A., McGeoch, D.J., Pringle, C.R., Wickner, R.B. (Eds.), 2000. Virus Taxonomy. Classification and Nomenclature of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, pp. 241-246.
69. Vapalahti O., Kallio-Kokko H., Salonen E.M., Brummer-Korvenkontio M., Vaheri A. Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J. Gen. Virol. 73:1992;829-838
70. Vapalahti O., Lundkvist Å., Kallio-Kokko H., Paukku K., Julkunen I., Lankinen H., Vaheri A. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J. Clin. Microbiol. 34:1996;119-125
71. Wu L.C., Tan T.H., Shahied S.I. Expression and characterization of the trans-activating protein Tax of human T-cell leukemia virus type I in Saccharomyces cerevisiae. J. Virol. 66:1992;7253-7261
72. Xu X., Severson W., Villegas N., Schmaljohn C.S., Jonsson C.B. The RNA binding domain of the Hantaan virus N protein maps to a central, conserved region. J. Virol. 76:2002;3301-3308
73. Yoshimatsu K., Arikawa J., Tamura M., Yoshida R., Lundkvist A., Niklasson B., Kariwa H., Azuma I. Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies. J. Gen. Virol. 77:1996;695-704
74. Zhu X.L., Ward C., Weissbach A. Control of Herpes simplex virus thymidine kinase gene expression in Saccharomyces cerevisiae by a yeast promoter sequence. Mol. Gen. Genet. 194:1984;31-41
75. Zöller L., Yang S., Gött P., Bautz E.K.F., Darai G. Use of recombinant nucleocapsid proteins of the Hantaan and Nephropathia epidemica serotypes of hantaviruses as immunodiagnostic antigens. J. Med. Virol. 39:1993a;200-207
76. Zöller L.G., Yang S., Gott P., Bautz E.K., Darai G. A novel μ-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. J. Clin. Microbiol. 31:1993b;1194-1199